MYnd Analytics Inc (MYAN)-医療機器分野:企業M&A・提携分析

◆英語タイトル:MYnd Analytics Inc (MYAN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011309
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MYnd Analytics Inc (MYnd), formerly CNS Response Inc is a biotechnology company that offers medication development programs. The company performs analysis and research, and develops medication for individual patients suffering from mental health and other issues. It provides an PEER Online, a cloud-based platform that enables qualified medical professionals to exchange objective, statistical neurophysiology-based data on individual patient medication response and outcomes. MYnd offers reference data and analytic tools for clinicians and researchers through the company’s psychiatric EEG evaluation registry or PEER online. The company’s PEER online is based on transformative technology used to help treat pediatric cancer. It caters to mental health patients and healthcare professionals across the US. MYnd is headquartered in Mission Viejo, California, the US.

MYnd Analytics Inc (MYAN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MYnd Analytics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
MYnd Analytics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
MYnd Analytics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
MYnd Analytics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
MYnd Analytics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
MYnd Analytics Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
CNS Response Acquires Rights To Patient Responsivity Data For Transcranial Magnetic Stimulation 10
Equity Offering 11
MYnd Analytics Raises USD8.8 Million in Public Offering of Shares 11
MYnd Analytics to Raise USD10 Million in Private Placement of Shares 13
MYnd Analytics Raises USD1 Million in Private Placement of Shares 14
CNS Response Completes Second Tranche Of Private Placement Of Shares For US$2 Million 15
CNS Response Withdraws Initial Public Offering 16
MYnd Analytics Inc – Key Competitors 17
MYnd Analytics Inc – Key Employees 18
MYnd Analytics Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Other Significant Developments 20
Jul 10, 2017: Harbin Clinic to Launch Personalized Mental Health Program Utilizing MYnd Analytics PEER Registry 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
MYnd Analytics Inc, Medical Equipment, Key Facts, 2016 2
MYnd Analytics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
MYnd Analytics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
MYnd Analytics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
MYnd Analytics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
MYnd Analytics Inc, Deals By Market, 2011 to YTD 2017 8
MYnd Analytics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
CNS Response Acquires Rights To Patient Responsivity Data For Transcranial Magnetic Stimulation 10
MYnd Analytics Raises USD8.8 Million in Public Offering of Shares 11
MYnd Analytics to Raise USD10 Million in Private Placement of Shares 13
MYnd Analytics Raises USD1 Million in Private Placement of Shares 14
CNS Response Completes Second Tranche Of Private Placement Of Shares For US$2 Million 15
CNS Response Withdraws Initial Public Offering 16
MYnd Analytics Inc, Key Competitors 17
MYnd Analytics Inc, Key Employees 18
MYnd Analytics Inc, Subsidiaries 19

★海外企業調査レポート[MYnd Analytics Inc (MYAN)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mercury NZ:企業の戦略・SWOT・財務情報
    Mercury NZ - Strategy, SWOT and Corporate Finance Report Summary Mercury NZ - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Abbott Laboratories (ABT):医療機器:M&Aディール及び事業提携情報
    Summary Abbott Laboratories (Abbott) develops, manufactures, and sells a diversified range of healthcare products including drugs, diagnostics, branded generics, and vascular and nutritional products. The company’s products comprise specialized medicines; medical diagnostic instruments and tests; mi …
  • ING-DiBa AG:企業の戦略的SWOT分析
    ING-DiBa AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Cenovus Energy Inc (CVE):企業の財務・戦略的SWOT分析
    Cenovus Energy Inc (CVE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • G1 Therapeutics Inc (GTHX):製薬・医療:M&Aディール及び事業提携情報
    Summary G1 Therapeutics Inc (G1 Therapeutics), formerly G Zero Therapeutics Inc, is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutics for the treatment of cancer. The company’s pipeline products include trilaciclib (G1T28), a CDK4/6 inhibitor to pres …
  • Xactware Solutions Inc:企業の戦略的SWOT分析
    Xactware Solutions Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Altius Minerals Corp:企業の戦略・SWOT・財務分析
    Altius Minerals Corp - Strategy, SWOT and Corporate Finance Report Summary Altius Minerals Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Coca-Cola Consolidated Inc (COKE):企業の財務・戦略的SWOT分析
    Coca-Cola Consolidated Inc (COKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Main Line Health System:企業の戦略的SWOT分析
    Main Line Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Recursion Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Recursion Pharmaceuticals Inc (Recursion Pharmaceuticals) is a biotechnology company that develops novel therapies for the treatment of rare genetic diseases. The company’s pipeline products include novel drugs for various diseases such as ataxia-telangiectasia, cerebral cavernous malformati …
  • The Jim Pattison Group:企業の戦略・SWOT・財務情報
    The Jim Pattison Group - Strategy, SWOT and Corporate Finance Report Summary The Jim Pattison Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ikon Science Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Ikon Science Ltd (Ikon Science) is an oil and gas company that offers software technology and consulting services. The company provides RockDoc software. Its RokDoc software offers access to rock physics forward or reverse modeling, seismic inversion, log data synthesis, inversion feasibilit …
  • Genera Biosystems Ltd (GBI)-製薬・医療分野:企業M&A・提携分析
    Summary Genera Biosystems Ltd (GBL) is a developer and commercializer of multiplexed molecular diagnostic testing products. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pat …
  • Symbolic Displays Inc:企業の戦略・SWOT・財務情報
    Symbolic Displays Inc - Strategy, SWOT and Corporate Finance Report Summary Symbolic Displays Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Dana Inc:企業の戦略・SWOT・財務情報
    Dana Inc - Strategy, SWOT and Corporate Finance Report Summary Dana Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Jerusalem Insurance Company PLC:企業の戦略・SWOT・財務情報
    Jerusalem Insurance Company PLC - Strategy, SWOT and Corporate Finance Report Summary Jerusalem Insurance Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • JCB Co., Ltd.:企業の戦略・SWOT・財務情報
    JCB Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary JCB Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • PGNiG SA (PGN):石油・ガス:M&Aディール及び事業提携情報
    Summary PGNiG SA (PGNiG) is a vertically integrated gas company. The company’s activities include domestic natural gas and crude oil production, development of natural gas and crude oil fields in Poland and abroad, provision of geological, geophysical and exploration services in Poland and abroad, i …
  • Teradyne Inc (TER):企業の財務・戦略的SWOT分析
    Teradyne Inc (TER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Whiting Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Whiting Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Whiting Petroleum Corp (Whiting Petroleum) is an independent oil and gas company that develops, produces, acquires and explores crude oil, natural gas and natural gas liquids (NGL) in the Rock …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆